심볼 | 시가총액 | 가격 | 변화 % | 거래량 | 상대적 거래량 | P/E | EPS 희석 순마진 | EPS 희석 성장 TTM YoY | 배당 수익 % 순마진 | 애널리스트 평점 |
---|---|---|---|---|---|---|---|---|---|---|
LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 DR | 717.38 T ARS | 14,800.000 ARS | −0.67% | 4.46 K | 0.34 | 118.54 | 124.85 ARS | +564.33% | 0.47% | — |
LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 717.38 T ARS | 13.900 USD | −15.50% | 812 | 0.94 | 107.88 | 124.85 ARS | +178.70% | 0.47% | — |
JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 369.74 T ARS | 11,500.000 ARS | +1.77% | 3.87 K | 0.39 | 37.47 | 306.92 ARS | +257.75% | 1.41% | — |
DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 369.74 T ARS | 1,340.000 ARS | 0.00% | 1 | 0.00 | — | — | — | — | — |
JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 369.74 T ARS | 10.800 USD | +0.93% | 375 | 0.16 | 34.10 | 306.92 ARS | +50.08% | 1.41% | — |
ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COM DR | 297.35 T ARS | 19,050.000 ARS | +2.28% | 651 | 0.17 | 8.13 | 2,343.37 ARS | +183.01% | 1.89% | — |
ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 297.35 T ARS | 17.850 USD | +3.18% | 95 | 0.46 | 7.38 | 2,343.37 ARS | +18.73% | 1.89% | — |
MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50) DR | 247.23 T ARS | 22,000.000 ARS | +1.85% | 401 | 0.32 | 24.90 | 883.37 ARS | +899.22% | 1.61% | — |
MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 247.23 T ARS | 20.500 USD | 0.00% | 11 | 0.23 | 22.49 | 883.37 ARS | +319.19% | 1.61% | — |
NVSNOVARTIS AG CEDEAR EACH 4 REP 1 DR | 204.39 T ARS | 28,675.000 ARS | +0.61% | 18 | 0.10 | 3.31 | 8,672.72 ARS | +474.20% | 3.63% | — |
ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1 DR | 201.68 T ARS | 32,175.000 ARS | +0.23% | 872 | 1.26 | 51.07 | 629.98 ARS | +270.79% | 0.97% | — |
ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 201.68 T ARS | 31.000 USD | 0.00% | 20 | 0.77 | 47.68 | 629.98 ARS | +55.55% | 0.97% | — |
TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1 DR | 196.75 T ARS | 25,850.000 ARS | 0.00% | 8 | 0.07 | 46.25 | 558.94 ARS | +251.94% | 0.15% | — |
AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25 DR | 196.11 T ARS | 35,400.000 ARS | +0.85% | 1.18 K | 0.63 | 52.23 | 677.80 ARS | +291.99% | 1.63% | — |
AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 196.11 T ARS | 34.600 USD | 0.00% | 10 | 0.60 | 49.46 | 677.80 ARS | +64.44% | 1.63% | — |
ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORD DR | 193.57 T ARS | 6,650.000 ARS | −3.62% | 1 | 0.02 | 125.73 | 52.89 ARS | +386.62% | 0.00% | — |
DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORD DR | 168.87 T ARS | 4,750.000 ARS | −5.19% | 106 | 1.50 | 0.93 | 5,080.23 ARS | +58.18% | 0.45% | — |
AMGNAMGEN INC CEDEAR EACH 30 REP 1 DR | 155.21 T ARS | 10,725.000 ARS | +1.42% | 903 | 0.06 | 43.06 | 249.09 ARS | −19.94% | 2.32% | — |
AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 155.21 T ARS | 10.000 USD | −4.31% | 12 | 0.26 | 38.90 | 249.09 ARS | −66.41% | 2.32% | — |
PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05 DR | 141.76 T ARS | 6,940.000 ARS | +0.14% | 6.46 K | 0.19 | 29.57 | 234.71 ARS | +224.10% | 3.63% | — |
PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 141.76 T ARS | 6.480 USD | +0.62% | 1.13 K | 0.19 | 26.75 | 234.71 ARS | +35.96% | 3.63% | — |
BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 117.74 T ARS | 21,550.000 ARS | +0.23% | 519 | 0.44 | — | — | — | 0.00% | — |
BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 117.74 T ARS | 21.000 USD | 0.00% | 2 | 0.04 | — | — | — | 0.00% | — |
GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001 DR | 110.79 T ARS | 24,725.000 ARS | +1.02% | 71 | 0.04 | — | −50.65 ARS | −118.38% | 1.74% | — |
GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 110.79 T ARS | 22.250 USD | +0.45% | 1 | 0.05 | — | −50.65 ARS | −107.71% | 1.74% | — |
MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1 DR | 108.19 T ARS | 23,500.000 ARS | +0.64% | 39 | 0.06 | 34.91 | 673.23 ARS | +275.14% | 1.99% | — |
GSKGSK PLC CEDEAR EACH REPR 1/4 ADR DR | 67.29 T ARS | 9,230.000 ARS | −0.54% | 172 | 0.17 | 29.98 | 307.84 ARS | +49.45% | 2.81% | — |
GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 67.29 T ARS | 8.750 USD | 0.00% | 3 | 0.18 | 27.54 | 307.84 ARS | −37.30% | 2.81% | — |
PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADR DR | 24.56 T ARS | 5,820.000 ARS | −0.17% | 28 | 0.05 | — | −689.04 ARS | −266.20% | 0.00% | — |
BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005 DR | 22.8 T ARS | 13,525.000 ARS | +2.27% | 376 | 0.39 | 19.44 | 695.64 ARS | +368.68% | 0.00% | — |
BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 22.8 T ARS | 12.700 USD | +0.79% | 49 | 2.15 | 17.69 | 695.64 ARS | +96.62% | 0.00% | — |
MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORD DR | 14.26 T ARS | 2,200.000 ARS | −0.23% | 5.86 K | 0.19 | — | −262.17 ARS | −63.54% | 0.00% | — |
MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD) DR | 14.26 T ARS | 2.410 USD | 0.00% | 3 | — | — | −262.17 ARS | +31.39% | 0.00% | — |
RICHLABORATORIOS RICHMOND SACIF | 153.02 B ARS | 1,880.000 ARS | −0.79% | 6.25 K | 0.24 | 849.14 | 2.21 ARS | — | 0.00% | — |
ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.43 B ARS | 110.000 ARS | +5.77% | 3 K | 0.61 | 6.77 | 16.26 ARS | — | 0.00% | — |